Existing biologics such as Canakinumab (monoclonal antibody), Anakinra (monoclonal antibody) and Rilonacept (fusion protein) can be exploited as therapeutics that restrain inflammation in COVID-19...
Research shows that neutralizing antibodies which are induced by vaccination can protect animals from HIV infection.
Developing a safe and effective HIV (Human Immunodeficiency Virus)...